Liu H - Search Results

1

Inhibition of FOXC2 restores epithelial phenotype and drug sensitivity in prostate cancer cells with stem-cell properties.

Paranjape AN, Soundararajan R, Werden SJ, Joseph R, Taube JH, Liu H, Rodriguez-Canales J, Sphyris N, Wistuba I, Miura N, Dhillon J, Mahajan N, Mahajan K, Chang JT, Ittmann M, Maity SN, Logothetis C, Tang DG, Mani SA. Paranjape AN, et al. Among authors: liu h. Oncogene. 2016 Nov 17;35(46):5963-5976. doi: 10.1038/onc.2015.498. Epub 2016 Jan 25. Oncogene. 2016. PMID: 26804168 Free PMC article.

2

Increased metabolites of 5-lipoxygenase from hypoxic ovarian cancer cells promote tumor-associated macrophage infiltration.

Wen Z, Liu H, Li M, Li B, Gao W, Shao Q, Fan B, Zhao F, Wang Q, Xie Q, Yang Y, Yu J, Qu X. Wen Z, et al. Among authors: liu h. Oncogene. 2015 Mar 5;34(10):1241-52. doi: 10.1038/onc.2014.85. Epub 2014 Mar 24. Oncogene. 2015. PMID: 24662827

3

Secretion-mediated STAT3 activation promotes self-renewal of glioma stem-like cells during hypoxia.

Almiron Bonnin DA, Havrda MC, Lee MC, Liu H, Zhang Z, Nguyen LN, Harrington LX, Hassanpour S, Cheng C, Israel MA. Almiron Bonnin DA, et al. Among authors: liu h. Oncogene. 2018 Feb 22;37(8):1107-1118. doi: 10.1038/onc.2017.404. Epub 2017 Nov 20. Oncogene. 2018. PMID: 29155422 Free PMC article.

4

p57Kip2 is an unrecognized DNA damage response effector molecule that functions in tumor suppression and chemoresistance.

Jia H, Cong Q, Chua JF, Liu H, Xia X, Zhang X, Lin J, Habib SL, Ao J, Zuo Q, Fu C, Li B. Jia H, et al. Among authors: liu h. Oncogene. 2015 Jul;34(27):3568-81. doi: 10.1038/onc.2014.287. Epub 2014 Sep 8. Oncogene. 2015. PMID: 25195859

5

Targeting heat-shock protein 90 with ganetespib for molecularly targeted therapy of gastric cancer.

Liu H, Lu J, Hua Y, Zhang P, Liang Z, Ruan L, Lian C, Shi H, Chen K, Tu Z. Liu H, et al. Cell Death Dis. 2015 Jan 15;6(1):e1595. doi: 10.1038/cddis.2014.555. Cell Death Dis. 2015. PMID: 25590805 Free PMC article.

6

Identification of evolutionarily conserved DNA damage response genes that alter sensitivity to cisplatin.

Gaponova AV, Deneka AY, Beck TN, Liu H, Andrianov G, Nikonova AS, Nicolas E, Einarson MB, Golemis EA, Serebriiskii IG. Gaponova AV, et al. Among authors: liu h. Oncotarget. 2017 Mar 21;8(12):19156-19171. doi: 10.18632/oncotarget.13353. Oncotarget. 2017. PMID: 27863405 Free PMC article.

7

Network analysis identifies an HSP90-central hub susceptible in ovarian cancer.

Liu H, Xiao F, Serebriiskii IG, O'Brien SW, Maglaty MA, Astsaturov I, Litwin S, Martin LP, Proia DA, Golemis EA, Connolly DC. Liu H, et al. Clin Cancer Res. 2013 Sep 15;19(18):5053-67. doi: 10.1158/1078-0432.CCR-13-1115. Epub 2013 Jul 30. Clin Cancer Res. 2013. PMID: 23900136 Free PMC article.

8

HSP90 inhibition downregulates DNA replication and repair genes via E2F1 repression.

Liu H, Lu Z, Shi X, Liu L, Zhang P, Golemis EA, Tu Z. Liu H, et al. Among authors: liu l. J Biol Chem. 2021 Aug;297(2):100996. doi: 10.1016/j.jbc.2021.100996. Epub 2021 Jul 21. J Biol Chem. 2021. PMID: 34302809 Free PMC article.

9

Reduced miRNA-218 expression in pancreatic cancer patients as a predictor of poor prognosis.

Li BS, Liu H, Yang WL. Li BS, et al. Among authors: liu h. Genet Mol Res. 2015 Dec 9;14(4):16372-8. doi: 10.4238/2015.December.9.5. Genet Mol Res. 2015. PMID: 26662432 Free article.

10

Partitioning defective 6 homolog alpha (PARD6A) promotes epithelial-mesenchymal transition via integrin β1-ILK-SNAIL1 pathway in ovarian cancer.

Lu Z, Yuan S, Ruan L, Tu Z, Liu H. Lu Z, et al. Among authors: liu h. Cell Death Dis. 2022 Apr 5;13(4):304. doi: 10.1038/s41419-022-04756-2. Cell Death Dis. 2022. PMID: 35379775 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96,755 results

Search Page

Filters